Androgen receptor assay

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
SERD 1 substance
Unknown / small molecule 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Ellipses Pharma Limited Commercial
    ELACESTRANT; VOSILASARM
    2023-507738-26-00 1 country 2024 n=25
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Ellipses Pharma Limited Commercial 1 Phase I/II 1
New trials by year
2024
1
← All indication landscapes